Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Noven Pharmaceuticals, Inc.

Noven Pharmaceuticals, Inc. Recalls

All product recalls associated with Noven Pharmaceuticals, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Oct 2024

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 21–40 of 51 recalls

Minivelle 0.1mg Patch (Noven) – adhesive defect (2018)

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Class IIModerate

FDASep 7, 2018Nationwide• Noven Pharmaceuticals, Inc.

Minivelle 0.05mg Patch (Noven) – adhesive defect (2018)

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Class IIModerate

FDASep 7, 2018Nationwide• Noven Pharmaceuticals, Inc.

Minivelle Estradiol Patch 0.1mg (Noven) – Adhesive Defect (2018)

Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

123

Page 2 of 3Next

Class IIModerate

FDAMay 4, 2018Nationwide• Noven Pharmaceuticals, Inc.

Minivelle Estradiol Patch 0.0375mg (Noven) – Adhesive Defect (2018)

Class IIModerate

FDAMay 4, 2018Nationwide• Noven Pharmaceuticals, Inc.

Daytrana (Noven) – Delivery System Defect (2018)

Defective Delivery System: Out of specification for adhesive transfer.

Class IIModerate

FDAApr 9, 2018Nationwide• Noven Pharmaceuticals, Inc.

Daytrana Patch (Noven) – Defective Delivery System (2017)

Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Class IIModerate

FDAAug 30, 2017Nationwide• Noven Pharmaceuticals, Inc.

Daytrana (Noven) – Defective Delivery System (2017)

Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Class IIModerate

FDAAug 30, 2017Nationwide• Noven Pharmaceuticals, Inc.

Daytrana (Noven) – Defective Delivery System (2017)

Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Class IIModerate

FDAAug 30, 2017Nationwide• Noven Pharmaceuticals, Inc.

Daytrana (Noven) – Defective Delivery System (2017)

Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Class IIModerate

FDAAug 30, 2017Nationwide• Noven Pharmaceuticals, Inc.

Minivelle Patch (Noven) – Defective Delivery System (2017)

Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.

Class IIILow

FDAApr 27, 2017Nationwide• Noven Pharmaceuticals, Inc.

Daytrana Patch (Noven) – Delivery System Defect (2016)

Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

Class IIModerate

FDAAug 22, 2016Nationwide• Noven Pharmaceuticals, Inc.

Daytrana Patch (Noven) – Defective Delivery System (2016)

Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

Class IIModerate

FDAAug 22, 2016Nationwide• Noven Pharmaceuticals, Inc.

Daytrana Patch (Noven) – Delivery System Defect (2016)

Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.

Class IIModerate

FDAAug 22, 2016Nationwide• Noven Pharmaceuticals, Inc.

Daytrana 30mg Patch (Noven) – Delivery System Defect (2015)

Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.

Class IIModerate

FDADec 21, 2015Nationwide• Noven Pharmaceuticals, Inc.